Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems.
- Published In:
- Cancers, 16(22) (2024)
- Authors:
- Nikitovic, Dragana, Kukovyakina, Ekaterina, Berdiaki, Aikaterini, Tzanakakis, Alexandros, Luss, Anna, Vlaskina, Elizaveta, Yagolovich, Anne, Tsatsakis, Aristides, Kuskov, Andrey
- Database ID:
- RPEP-08958
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08958APA
Nikitovic, Dragana; Kukovyakina, Ekaterina; Berdiaki, Aikaterini; Tzanakakis, Alexandros; Luss, Anna; Vlaskina, Elizaveta; Yagolovich, Anne; Tsatsakis, Aristides; Kuskov, Andrey. (2024). Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems.. Cancers, 16(22). https://doi.org/10.3390/cancers16223768
MLA
Nikitovic, Dragana, et al. "Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems.." Cancers, 2024. https://doi.org/10.3390/cancers16223768
RethinkPeptides
RethinkPeptides Research Database. "Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide i..." RPEP-08958. Retrieved from https://rethinkpeptides.com/research/nikitovic-2024-enhancing-tumor-targeted-therapy
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.